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Fig 2. A, Histopathologic appearance of dilation of pores of hair follicles and fibromucinous
stroma in the papillary and perifollicular dermis. B, Mucinous material was seen among
fibroblasts in the perifollicular dermis. C, Specimen staining with alcian blue at pH 2.5 showed
not only diffuse deposition of amorphous materials in the papillary dermis but also deposits in
the perifollicular dermis. D, Elastica van Gieson stain showed an absence of collagen and
elastic fibers in the mucin-deposited area, and normal collagen and elastic fibers in the
unaffected papillary dermis. (A to D, Original magnifications: A, C, and D, 340; B, 3400.)
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Photo-induced erythema multiforme
associated with vandetanib administration
To the Editor: Vandetanib is a tyrosine kinase
inhibitor used for the treatment of unresectable,
locally advanced, or metastatic medullary thyroid
cancer. Photo-induced erythema multiforme (PEM)
is a rare entity described in relation with several
drugs. We report a case of PEM induced by
vandetanib.
A 66-year-old man presented with a 7 day-history
of pruritic skin lesions. In April 2013, the patient was
given a diagnosis of a medullary thyroid carcinoma
stage IVand treated with subtotal thyroidectomy and
oral vandetanib (300 mg/d). The skin lesions
appeared on his face 3weeks after the administration
of vandetanib and then spread to other photo-
exposed areas. Physical examination revealed
well-demarcated scaly erythematous papules and
plaques, with eczematous appearance on the face,
Fig 1. Photo-induced erythema multiforme. A and B,
Targetoid lesions on both hands. C, Superficial perivas-
cular and interstitial dermatitis with eosinophils, interface
dermatitis of vacuolar type with abundant degenerated
keratinocytes, and mild spongiosis. (C, Hematoxylin-eosin
stain; original magnification: 3200.)
Fig 2. Photo-test during vandetanib intake showed a
diminished minimal erythema dose (MED) after ultraviolet
(UV) A exposure (\1 J/cm2) (second row). MED after UVB
exposure ( first row).
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lesions were also observed on both palms (Fig 1). He
denied recent infectious processes, including
herpes simplex, or introduction of any other
drug. Nonphoto-exposed areas such as the trunk,
submental region, and eyelids were spared. There
was no mucosal involvement. Two skin biopsy
specimens showed superficial perivascular and
interstitial dermatitis with eosinophils, interface
dermatitis of vacuolar type with abundant degene-
rated keratinocytes, and mild spongiosis (Fig 1).
Antinuclear antibodies were negative. Photo-test
showed a diminished minimal erythema dose for
ultraviolet A (\1 J/cm2) during vandetanib intake
(Fig 2). According to these findings, the diagnosis of
PEM was made.Vandetanib is a tyrosine kinase inhibitor that
selectively targets vascular endothelial growth
factor receptor-2, epidermal growth factor receptor,
and RET (rearranged during transfection) proto-
oncogene.1 It was initially developed for the
treatment of nonsmall-cell lung cancer and
colorectal cancer, but it has also demonstrated
effects in medullary and papillary thyroid
cancer mediated by RET inhibition,1 so it was
approved for this purpose by the Food and
Drug Administration in 2011. Its main adverse
events are diarrhea, high blood pressure, elevated
liver enzymes, and QTc interval prolongation.1
Reported mucocutaneous complications included
photosensitivity, acneiform eruption, dry skin,
hand-foot reaction,2 and Stevens-Johnson syn-
drome.3 Photosensitivity is the most characteristic
reaction. It has been observed in up to 37%
of patients after median treatment duration of
8 weeks.2 It can manifest as exaggerated sunburn,
erythematous or lichenoid eruption, and less
frequently as photo-induced subacute cutaneous
lupus erythematosus or PEM.2 This last entity is rare
and is presented clinically equal to classic erythema
multiforme. It can be associated with drugs,
herpes simplex virus infection, or polymorphous
light eruption.4 Rodrıguez-Pazos et al4 reviewed the
drug-induced PEM cases reported at the moment in
the literature. In our case, the drug discontinuation
was not necessary because the lesions resolved after
2 weeks of extreme photoprotection and topical
steroid treatment. Although we cannot guarantee
100% that ultraviolet radiation was involved in
the pathogenesis of the cutaneous reaction, it is
somehow associated because of the clear decrease of
minimal erythema dose for ultraviolet A.
In conclusion, we present a case of PEM second-
ary to vandetanib. It is mandatory to inform patients
Fig 1. Repigmented hair overlying melanoma in situ of
scalp. Slowly darkening patch of previously white hair on
superior scalp.
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protection to avoid such photosensitivity reactions.
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Repigmentation of hair associated with
melanoma in situ of scalp
To the Editor: An 88-year-old woman presented
with a slowly darkening patch of previously white
hair on her superior scalp (Fig 1). On physical
examination, she had an underlying 6.5- 3 3-cm
scaly, irregularly pigmented plaque on her superior
scalp.
A shave biopsy of the plaque showed actinic
keratosis as well as melanoma in situ, lentigomaligna
type, extending along the dermoepidermal junction
and down the hair follicle. Further scouting punch
biopsies were performed to identify the extent of
disease, including peripheral areas that contained
pigmented hair shafts despite clinically normal-
appearing epidermis. Histopathology of these repeat
biopsies showed multiple foci of actinic keratosis
and a few areas with atypical melanocytes suspicious
for, but not diagnostic of, melanoma in situ.
Interestingly, there were 2 areas that showed
pigmented hair shafts and hair bulbs with
histopathologically normal dendritic melanocytesand no evidence of overlying melanoma in situ or
actinic keratosis.
Normal hair follicle pigmentation and physiologic
graying are under complex genetic, metabolic,
enzymatic, and signaling control.1,2 The mechanism
responsible for our patient’s follicular repigmenta-
tion is unclear, although we believe it is most
likely due to her overlying melanoma in situ or
chronic sun damage. It is unlikely due to
medication use because the patient was not taking
any medications previously associated with hair
repigmentation.
Because the dendritic melanocytes in our
patient’s hair bulb appeared normal on histologic
examination, the follicular melanocytes were more
likely stimulated to produce melanin by external
signals rather than by a direct effect of melanoma
cells repopulating the hair bulb. These signals
could be from the lentigo maligna cells themselves
or by changes in the microenvironment. To our
knowledge, there is 1 previously reported case
of hair repigmentation associated with lentigo
maligna, which also showed no invasion of the
hair follicles by the melanoma cells.3 In that case,
the patient’s hair grew back gray after the
melanoma was treated by radiotherapy, suggesting
that normal hair physiology was restored once
the malignant cells were removed. If these
signals arise from the lentigo maligna, it would
be interesting to clarify how the neoplastic
cells could upregulate melanogenesis in nearby
normal follicular melanocytes, and which of the
numerous cytokines, enzymes, and metabolites
required for normal pigmentation were involved
in the process.
The repigmentationcouldalsobe related to chronic
sun exposure and actinic damage, as evidenced by the
presence of actinic keratoses. In particular, chronic
sun exposure causes upregulation of manymolecules
associated with melanogenesis, including stem cell
